Oct 19, 2023 / 10:30AM GMT
Operator
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech conference call on the 9 months 2023 results. Today's conference is being recorded.
At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO of Sartorius Group. Please go ahead, sir.
Joachim Kreuzburg - Sartorius Aktiengesellschaft - Chairman of Executive Board, CEO & Interim CFO
Thank you very much and also hello and good day from my side. As always, I would like to kick it off by walking you through the highlights of the past 3 months and the 9 months of 2023, and then Rainer will walk you through the detailed financial results for the Sartorius Group. And then after that, Rene, CEO of Sartorius Stedim Biotech, will talk about the Sartorius Stedim Biotech numbers and therefore, also highlighting the bioprocessing business in more detail as well.
So again, let me start by talking about the most important point over the last couple of months and weeks. So obviously, and I think everyone is following the industry quite closely and seeing also the
Q3 2023 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers